Home

Zydus Lifesciences Ltd EPS

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

EPS

₹ 46.33

Last updated on: Oct 17, 2025

Key Highlights

  • The Earning per Share of Zydus Lifesciences Ltd is ₹ 46.33 as of 17 Oct 25 .
  • The earning per share of Zydus Lifesciences Ltd changed from ₹ 10.74 to ₹ 14.58 over 9 quarters. This represents a CAGR of 14.55% .

Historical Earning per Share of Zydus Lifesciences Ltd

No data available

* All values are in

Company Fundamentals for Zydus Lifesciences Ltd

Market Cap

99,345 Cr

EPS

46.3

P/E Ratio (TTM)

21.3

P/B Ratio (TTM)

4.2

Day’s High

990.7

Day’s Low

977.75

DTE

0.1

ROE

18.9

52 Week High

1059.0

52 Week Low

797.05

ROCE

22.1

Market Price of Zydus Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Oct 2025987.3
16 Oct 2025984
15 Oct 2025977.3
14 Oct 2025979.15
13 Oct 2025993.55
10 Oct 2025993.45
09 Oct 2025996.05
08 Oct 2025986.15
07 Oct 2025987.75
06 Oct 2025994.3

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

che

Weakness

3

che

Opportunity

0

che

Threats

2

che

BlinkX Score for Zydus Lifesciences Ltd

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

99,345

Asset Value

Value addition

4.5 X

18,014

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Zydus Lifesciences Ltd99345
Sun Pharmaceutical Industries Ltd402872
Divis Laboratories Ltd175706
Cipla Ltd127449
Torrent Pharmaceuticals Ltd121119
Dr Reddys Laboratories Ltd104827

Historical Market Cap of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Zydus Lifesciences Ltd News Hub

Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr

Revenue from operations jumped 20.77% year on year (YoY) to Rs 6,207.5 crore in the quareter ended 3

Read more

09 Aug 24

Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter

Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June 2024 as a

Read more

09 Aug 24

Zydus receives USFDA approval for Valbenazine Capsules

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (

Read more

09 Aug 24

Zydus Lifesciences Ltd soars 1.83%, rises for third straight session

Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting at Rs 1296.

Read more

08 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for EPS of Zydus Lifesciences Ltd

What is the EPS of Zydus Lifesciences Ltd stock?

The Earnings Per Share (EPS) of Zydus Lifesciences Ltd is 46.33. An EPS is the amount of net income attributed to each share of a common stock.

How is Zydus Lifesciences Ltd EPS calculated?

The EPS of Zydus Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Zydus Lifesciences Ltd report its EPS?

Zydus Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Zydus Lifesciences Ltd EPS?

Factors that influence the EPS of Zydus Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Zydus Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Zydus Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions